Your browser doesn't support javascript.
loading
Structural insights into probe-dependent positive allosterism of the GLP-1 receptor.
Bueno, Ana B; Sun, Bingfa; Willard, Francis S; Feng, Dan; Ho, Joseph D; Wainscott, David B; Showalter, Aaron D; Vieth, Michal; Chen, Qi; Stutsman, Cynthia; Chau, Betty; Ficorilli, James; Agejas, Francisco J; Cumming, Graham R; Jiménez, Alma; Rojo, Isabel; Kobilka, Tong Sun; Kobilka, Brian K; Sloop, Kyle W.
Affiliation
  • Bueno AB; Lilly, S.A., Alcobendas, Spain.
  • Sun B; ConfometRx, Santa Clara, CA, USA.
  • Willard FS; Quantitative Biology, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.
  • Feng D; ConfometRx, Santa Clara, CA, USA.
  • Ho JD; Lilly Biotechnology Center San Diego, San Diego, CA, USA.
  • Wainscott DB; Quantitative Biology, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.
  • Showalter AD; Diabetes and Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.
  • Vieth M; Lilly Biotechnology Center San Diego, San Diego, CA, USA.
  • Chen Q; Discovery Chemistry Research and Technologies, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.
  • Stutsman C; Diabetes and Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.
  • Chau B; Lilly Biotechnology Center San Diego, San Diego, CA, USA.
  • Ficorilli J; Diabetes and Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.
  • Agejas FJ; Lilly, S.A., Alcobendas, Spain.
  • Cumming GR; Lilly, S.A., Alcobendas, Spain.
  • Jiménez A; Lilly, S.A., Alcobendas, Spain.
  • Rojo I; Lilly, S.A., Alcobendas, Spain.
  • Kobilka TS; ConfometRx, Santa Clara, CA, USA.
  • Kobilka BK; ConfometRx, Santa Clara, CA, USA. kobilka@stanford.edu.
  • Sloop KW; Diabetes and Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA. sloop_kyle_w@lilly.com.
Nat Chem Biol ; 16(10): 1105-1110, 2020 10.
Article in En | MEDLINE | ID: mdl-32690941
Drugs that promote the association of protein complexes are an emerging therapeutic strategy. We report discovery of a G protein-coupled receptor (GPCR) ligand that stabilizes an active state conformation by cooperatively binding both the receptor and orthosteric ligand, thereby acting as a 'molecular glue'. LSN3160440 is a positive allosteric modulator of the GLP-1R optimized to increase the affinity and efficacy of GLP-1(9-36), a proteolytic product of GLP-1(7-36). The compound enhances insulin secretion in a glucose-, ligand- and GLP-1R-dependent manner. Cryo-electron microscopy determined the structure of the GLP-1R bound to LSN3160440 in complex with GLP-1 and heterotrimeric Gs. The modulator binds high in the helical bundle at an interface between TM1 and TM2, allowing access to the peptide ligand. Pharmacological characterization showed strong probe dependence of LSN3160440 for GLP-1(9-36) versus oxyntomodulin that is driven by a single residue. Our findings expand protein-protein modulation drug discovery to uncompetitive, active state stabilizers for peptide hormone receptors.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Allosteric Regulation / Glucagon-Like Peptide-1 Receptor Type of study: Prognostic_studies Language: En Journal: Nat Chem Biol Journal subject: BIOLOGIA / QUIMICA Year: 2020 Document type: Article Affiliation country: Spain Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Allosteric Regulation / Glucagon-Like Peptide-1 Receptor Type of study: Prognostic_studies Language: En Journal: Nat Chem Biol Journal subject: BIOLOGIA / QUIMICA Year: 2020 Document type: Article Affiliation country: Spain Country of publication: United States